London Bridge Hospital

27 Tooley Street

London

SE1 2PR

 

Princess Grace Hospital

London Digestive Centre

Welbeck Street

London

W1G 8DW

The Sloane Hospital

125 Albermarle Road

Beckenham

London

BR3 5HS

 

e: pa@liverlondon.org

t: +44 20 7234 2240

@willalazawi

 

Non-Alcoholic Fatty Liver

Non-alcoholic fatty liver (NAFL) is one of the most common causes of liver disease.  People with diabetes, obesity, raised cholesterol and psoriasis are at particular risk, but it also affects many people who do not have these risk factors.  It is often only discovered after noticing abnormal liver blood tests and performing appropriate investigations. 10-20% of people with fatty liver  have the aggressive form of the disease called non-alcoholic steatohepatitis, or NASH for short.

 

As with other liver diseases,  most patients with fatty liver or NASH will not have any symptoms, but without treatment, patients are at risk of progressive liver disease.   Although there are no drugs licensed to treat NASH, many new drugs are currently in clinical trials and Professor Alazawi is an internationally recognised research leader in this field.  

 

The cornerstone of treatment is behaviour and lifestyle change focussing on weight loss and exercise.  Professor Alazawi is networked with dieticians, physiotherapists and behaviour specialists who can help patients achieve the targets needed to improve liver health and reduce the risk of complications.

Abnormal liver tests

 

Viral Hepatitis

 

Alcoholic Liver Disease

  • Twitter Social Icon
  • LinkedIn Social Icon